97590573 - ENTOS

Information

• Trademark
• 97590573

• Source

• Serial Number

  97590573

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth

• Filing Date

  September 14, 2022
  2 years ago

• Transaction Date

  December 31, 2024
  8 days ago

• Status Date

  July 02, 2024
  6 months ago

• Published for Opposition Date

  May 07, 2024
  8 months ago

• Location Date

  July 02, 2024
  6 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  HENRY, NAKIA

• Attorney Docket Number

  079440.00014

  Attorney Name

  Theodore R. Remaklus

  Law Office Assigned Location Code

  O20

• Owners

  • ENTOS PHARMACEUTICALS INC

Case File Statements

• GS0091: Nucleic acid sequencers for scientific purposes
• GS0051: Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, namely, viral infections, bacterial infections, fungal infections, parasitic infections and prion diseases, infections of multiple organ systems, namely, the lung in the name of pneumonia, kidneys in the name of pyelonephritis, gastrointestinal track in the nature of gastritis, enteritis, colitis, systemic blood infections in the nature of sepsis/septic shock, skin infections in the nature of cellulitis, central nervous system in the nature of meningitis, encephalitis, walled off infections in the nature of abscesses, liver in the nature of hepatitis, head and neck infections in the nature of conjunctivitis, uveitis, sinusitis; chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic respiratory, pulmonary and lung diseases, chronic inflammatory diseases, chronic cardiovascular diseases, chronic liver diseases, chronic kidney diseases, chronic bone diseases, chronic eye diseases, chronic oral diseases, chronic blood diseases, chronic spleen diseases, chronic pancreatic diseases, chronic thyroid diseases, chronic reproductive disease, chronic gastrointestinal diseases, chronic skin diseases, chronic muscle diseases, chronic bone diseases and cancers in the nature of hematological cancers and solid organ cancers; vaccines that are viral, bacterial, fungal for human use; vaccines that are viral, bacterial, fungal for veterinary use; therapeutic and preventative cancer vaccines for human use; therapeutic and preventative cancer vaccines for veterinary use; diagnostic preparations for medical purposes for detecting genetic predispositions; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, cancer, inflammatory diseases and disorders, namely, inflammatory bowel diseases and disorders, inflammatory connective tissue diseases and disorders, inflammatory pelvic diseases and disorders, inflammatory muscle diseases and disorders, asthma, coeliac disease, hepatitis which is viral, alcoholic, autoimmune, inflammatory bowel disease, namely, Crohn's and ulcerative colitis, fatty liver disease, diabetes, endometriosis, arthritis, obesity, autoimmune diseases and disorders, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, genetic diseases and disorders, infectious diseases, namely, blood infections, respiratory infections, topical infections, cardiovascular diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, hematological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, eczema, acne, shingles, hives, rosacea, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, namely, urological diseases and disorders, infertility, sexually transmitted diseases, acute renal failure, benign ptostatic hyperplasia, endometrial ablation, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namely, rare neurological and nervous system diseases and other mental illnesses, rare respiratory, pulmonary and lung diseases, rare inflammatory diseases, rare cardiovascular diseases, rare liver diseases, rare kidney diseases, rare bone diseases, rare eye diseases, rare oral diseases, rare blood diseases, rare spleen diseases, rare pancreatic diseases, rare thyroid diseases, rare reproductive disease, rare gastrointestinal diseases, rare skin diseases, rare muscle diseases, rare bone diseases; cell culture media for cultivating human, animal, plant or microorganism cells for use in the biotechnological industry
• TR0010: The English translation of the word "Entos" in the mark is "within".
• GS0011: Reagents for scientific purposes for use in nucleic acid isolation and purification; cell culture media for laboratory use for use in the biotechnological industry; diagnostic reagents for clinical laboratory use; diagnostic preparations for clinical laboratory use
• GS0101: Medical devices for the qualitative detection and testing of DNA and RNA in human specimens for the detection of influenza viruses and nucleic acid detection

Case File Event Statements

• 9/17/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/29/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/26/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/27/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/27/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/27/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/27/2023 - a year ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 9/27/2023 - a year ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 11/16/2023 - a year ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/16/2023 - a year ago

  14 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 11/16/2023 - a year ago

  9 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 11/16/2023 - a year ago

  10 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 11/16/2023 - a year ago

  11 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 3/6/2024 - 10 months ago

  13 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 3/8/2024 - 10 months ago

  15 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 3/11/2024 - 10 months ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/11/2024 - 10 months ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/11/2024 - 10 months ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/11/2024 - 10 months ago

  19 - ASSIGNED TO LIE Type: ALIE

• 3/12/2024 - 10 months ago

  20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/22/2024 - 9 months ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/28/2024 - 9 months ago

  22 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 4/17/2024 - 8 months ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/7/2024 - 8 months ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/7/2024 - 8 months ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/2/2024 - 6 months ago

  26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/7/2024 - 3 months ago

  28 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/7/2024 - 3 months ago

  27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 10/7/2024 - 3 months ago

  30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/30/2024 - 9 days ago

  32 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/7/2024 - 3 months ago

  31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/7/2024 - 3 months ago

  29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP